Cognition Therapeutics
Price & Volume
Stats
See moreOpen | $0.36 |
Previous Close | $0.36 |
Day Range | $0.35-$0.37 |
52W Range | $0.30-$2.95 |
Market Cap | $23M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.86 |
News
See moreYahoo Finance • 21 days ago
Cognition Therapeutics Presents Results at AD/PD 2025 Showing Impact of Zervimesine (CT1812) on Alzheimer’s Disease Processes
Yahoo Finance • 28 days ago
Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease in Podium Presentation at AD/PD 2025
Yahoo Finance • last month
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
Yahoo Finance • last month
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
About
CEO | Ms. Lisa Ricciardi |
Address | 2500 Westchester Ave., Purchase, NY, United States, 10577 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
